Inbec是哪产的呢？

Where is Suimeikai produced? Let’s take a look at the manufacturer of Suimeikai Inbec.

Inbec is an innovative AIDS treatment drug produced by ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK). It is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier and few drug interactions.

Taking one tablet once a day can significantly reduce the medication burden of AIDS patients, thereby improving their medication compliance and significantly improving their quality of life.

According to Medical Companion Travel, Suimeikan Inbec, which is available in China, is relatively expensive and most patients cannot afford it. The price of Suimeikan Inbec in China is 2,880$/month. Patients can choose to buy Suimeikai, which is available in India and is relatively cheap. Inbec, produced by the Indian company Emcure, has a box of 30 tablets and sells for about RMB 1,000.

Clinical data on Trimax Inbec are limited, and the most commonly reported adverse reactions that are possibly or probably related to dolutegravir and abacalongvir/lamivudine are nausea (12%), insomnia (7%), dizziness (6%), and headache (6%). Adverse reactions (nausea, vomiting, diarrhea, pyrexia, drowsiness, rash) occur frequently in patients with abacavir hypersensitivity reactions. 

Patients experiencing the above symptoms should be carefully evaluated for the presence of this hypersensitivity reaction. Very rarely, erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis have been reported and abacavir hypersensitivity cannot be excluded. In such cases, abacavir-containing medicinal products should be discontinued. 

Suimeikan Inbec is a core drug based on DTG, an integrase inhibitor. In the real world, antiviral treatment-naïve patients treated with DTG are better than RAL (Ascent), DRV/r (darunavir), and EFV (efavirenz). ) and ATV/r (atazanavir) have a lower proportion of central nervous system-related (CNS) adverse events. Therefore, the drug safety of Trimax Inbec, which is based on DTG integrase inhibitors, has proven to be controllable.

The above is the introduction of the manufacturer of Suimeikan Inbec and the medicine of Suimeike provided by our Medical Companion Travel Overseas Medical Consulting Service Company.